Jeffrey E. Russel

Array ( [id] => 993691 [patent_doc_number] => 06916790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Treatment of osteoporosis' [patent_app_type] => utility [patent_app_number] => 09/972809 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10005 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916790.pdf [firstpage_image] =>[orig_patent_app_number] => 09972809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782816 [patent_doc_number] => 06992064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres' [patent_app_type] => utility [patent_app_number] => 10/398467 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5280 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992064.pdf [firstpage_image] =>[orig_patent_app_number] => 10398467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732907 [patent_doc_number] => 07037890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Therapeutic agents and methods of use thereof for the modulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/972772 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14162 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037890.pdf [firstpage_image] =>[orig_patent_app_number] => 09972772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985068 [patent_doc_number] => 20020098173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Modulators of amyloid aggregation' [patent_app_type] => new [patent_app_number] => 09/972475 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37245 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098173.pdf [firstpage_image] =>[orig_patent_app_number] => 09972475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537844 [patent_doc_number] => 20020193395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Methods and compositions to treat glycosaminoglycan-associated molecular interactions' [patent_app_type] => new [patent_app_number] => 09/970148 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13110 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193395.pdf [firstpage_image] =>[orig_patent_app_number] => 09970148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382750 [patent_doc_number] => 20020120105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Polarization switching to control crystal form' [patent_app_type] => new [patent_app_number] => 09/965751 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8034 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120105.pdf [firstpage_image] =>[orig_patent_app_number] => 09965751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663190 [patent_doc_number] => 07101851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'IgE receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/381112 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 167013 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101851.pdf [firstpage_image] =>[orig_patent_app_number] => 10381112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209664 [patent_doc_number] => 06713453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Fibrin/fibrinogen-binding conjugate' [patent_app_type] => B2 [patent_app_number] => 09/963156 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5427 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713453.pdf [firstpage_image] =>[orig_patent_app_number] => 09963156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756335 [patent_doc_number] => 20030004112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Cell-permeable protein inhibitors of calpain' [patent_app_type] => new [patent_app_number] => 09/962967 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12341 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004112.pdf [firstpage_image] =>[orig_patent_app_number] => 09962967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922906 [patent_doc_number] => 20020115596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => new [patent_app_number] => 09/961236 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12596 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115596.pdf [firstpage_image] =>[orig_patent_app_number] => 09961236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397433 [patent_doc_number] => 20040038907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Angiogenic agents and their uses' [patent_app_type] => new [patent_app_number] => 10/380983 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3671 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038907.pdf [firstpage_image] =>[orig_patent_app_number] => 10380983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6158770 [patent_doc_number] => 20020147146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Glycogen synthase kinase-3 inhibitors' [patent_app_type] => new [patent_app_number] => 09/951902 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21641 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147146.pdf [firstpage_image] =>[orig_patent_app_number] => 09951902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178554 [patent_doc_number] => 20020156235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Process for preparing peptide derivatized oligomeric compounds' [patent_app_type] => new [patent_app_number] => 09/949474 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26762 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156235.pdf [firstpage_image] =>[orig_patent_app_number] => 09949474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364722 [patent_doc_number] => 20040092015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Method for binding, in solution, a peptide and a lipophilic vector and uses thereof' [patent_app_type] => new [patent_app_number] => 10/380094 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17575 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092015.pdf [firstpage_image] =>[orig_patent_app_number] => 10380094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1206317 [patent_doc_number] => 06716962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Extractive purification of lipopeptide antibiotics' [patent_app_type] => B2 [patent_app_number] => 09/948374 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7343 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716962.pdf [firstpage_image] =>[orig_patent_app_number] => 09948374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 513348 [patent_doc_number] => RE039497 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-02-27 [patent_title] => 'Storage of materials' [patent_app_type] => reissue [patent_app_number] => 09/939689 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6789 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039497.pdf [firstpage_image] =>[orig_patent_app_number] => 09939689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1242653 [patent_doc_number] => RE038385 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Storage of materials' [patent_app_type] => E1 [patent_app_number] => 09/939688 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6758 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038385.pdf [firstpage_image] =>[orig_patent_app_number] => 09939688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361717 [patent_doc_number] => 20040014674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Gpe analogs' [patent_app_type] => new [patent_app_number] => 10/362266 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6489 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014674.pdf [firstpage_image] =>[orig_patent_app_number] => 10362266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987314 [patent_doc_number] => 20020099013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Active agent delivery systems and methods for protecting and administering active agents' [patent_app_type] => new [patent_app_number] => 09/933708 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17349 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099013.pdf [firstpage_image] =>[orig_patent_app_number] => 09933708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1211949 [patent_doc_number] => 06709679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-23 [patent_title] => 'Antineoplastic conjugates of transferin, albumin and polyethylene glycol' [patent_app_type] => B2 [patent_app_number] => 09/931940 [patent_app_country] => US [patent_app_date] => 2001-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14160 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709679.pdf [firstpage_image] =>[orig_patent_app_number] => 09931940 [rel_patent_id] =>[rel_patent_doc_number] =>)